Validated HPLC Method for Simultaneous Determination of Aripiprazole and CoAdministered Clonazepam in Spiked Human Plasma

2017 ◽  
Vol 3 (1) ◽  
pp. 57-61 ◽  
Author(s):  
Christine M. El-Maraghy ◽  
Hesham Salem ◽  
Sawsan M. Amer ◽  
Marianne Nebsen
2018 ◽  
Vol 1 (7) ◽  
pp. 475-482 ◽  
Author(s):  
Rania Sayed ◽  
Manal El-Masry ◽  
Wafaa Hassan ◽  
Magda El-Mammli ◽  
Abdalla Shalaby ◽  
...  

Author(s):  
Jasmin Shah ◽  
M. Rasul Jan ◽  
Sultan Shah ◽  
M. Naeem Khan

A reversed phase high performance liquid chromatographic method has been developed for the simultaneous determination of cefaclor and ceftriaxone cephalosporin antibiotic. The developed method has been validated and applied to mixtures of the commercial formulation and spiked human plasma. A mediterranea C<sub>18</sub> column (4.6 × 250 mm) was used with isocratic solvent delivery system and UV-visible detector. Different experimental parameters like solvent composition (acetonitrile: methanol: triethyl amine buffer 1:1:2 (v/v), flow rate of mobile phase (0.6 mLmin<sup>-1</sup>), pH of the buffer (7), and wavelength (260 nm) were optimized for effective separation and esolution of the analyte peaks. The separation was achieved in 6 min with retention times of 4.94 ± 0.056 min and 3.39 ± 0.022 min for cefaclor and ceftriaxone respectively. The linear range for both the studied drugs was found to be 0.5-250 μgmL<sup>-1</sup> with r<sup>2</sup> of 0.9987 (cefaclor) and 0.9997 (ceftriaxone). The limit of detection (3.3 σ/S) was found to be 2.34 × 10<sup>-2</sup> μgmL−1 and 1.70 × 10−2 μgmL<sup>-1</sup>, respectively, for cefaclor and ceftriaxone. Similarly limit of quantification (10σ/S) was 7.10 × 10−2 μgmL<sup>-1</sup> for cefaclor and 5.15 × 10−2 μgmL<sup>-1</sup> for ceftriaxone. The chromatographic procedure was applied to commercial formulations and spiked human plasma and the results were compared with literature HPLC method.


2004 ◽  
Vol 72 (2) ◽  
pp. 143-155 ◽  
Author(s):  
M. Sultan ◽  
H. Abdine ◽  
N. Zoman ◽  
F. Belal

A reversed-phase HPLC method with spectrophotometric detection was developed for the simultaneous determination of labetalol (LBT) and hydrochloro-thiazide (HCD). The chromatographic separation was performed using a Microbondapak C18 column (4.6 i.d. x 250 nm) and paracetamol as internal standard. A mobile phase consisting of 0.05 M phosphate buffer/acetonitrile of pH 4 (7:3) at a flow rate of 0.7 ml/min was used. The detection was affected spectrophotornetrically at 302 nm. The working concentration range was 0.3–10 µg/ml with detection limits of 0.05 µg/ml for both drugs. The lower quantitation limit was 0.25 µg/ml in the two cases. The method was successfully applied to tablets, the % recoveries were 99.45 ± 0.68 for LBT and 99.79 ± 0.75 for HCD. The method was extended to the in-vitro determination in spiked human plasma. The % recoveries were 91.12 ± 0.33 for LBT and 91.37 ± 0.40 for HCD. The interday and intraday precision and accuracy were evaluated in plasma by calculating the % RSD (n=5) and the % error and were found to be in the ranges of 1.18–4.1% and 0.38–0.36% for both drugs, respectively.


2007 ◽  
Vol 45 (1) ◽  
pp. 120-124
Author(s):  
Ahmad H. Malkawi ◽  
Abeer M. Al-Ghananeem ◽  
Shama Nasim ◽  
Jose de Leon ◽  
Peter A. Crooks

2006 ◽  
Vol 830 (2) ◽  
pp. 207-211 ◽  
Author(s):  
Mohammad-Reza Rouini ◽  
Yalda Hosseinzadeh Ardakani ◽  
Faezeh Soltani ◽  
Hassan Y. Aboul-Enein ◽  
Alireza Foroumadi

Sign in / Sign up

Export Citation Format

Share Document